Real-World EGFR Testing in Patients with Surgically Resected Stage I-III Non-Small Cell Lung Cancer (NSCLC) in US Community Oncology Practices
07:30am - 03:45pm EDT - March 31, 2023
07:30am - 03:45pm EDT - March 31, 2023
Author(s):
- Anne Shah, PhD, AstraZeneca Pharmaceuticals, LP
Tags: Outcomes and Health Services Research
| Display Label | Action |
|---|---|
| AC23P12 - Real-World EGFR Testing in Patients with Surgically Resected Stage I-III Non-Small Cell Lung Cancer (NSCLC) in US Community Oncology Practices | Download MP3 |
| 012-General Poster Session | Download Resource |
